GKB Ophthalmics Ltd
GKB Ophthalmics Ltd (GKB) last traded at ₹65, a market capitalisation of ₹32.8 crore, on a P/E of 8.93. Over the past 52 weeks the stock has ranged between ₹45.2 and ₹84. GKB Ophthalmics Ltd last reported results for the quarter ended Jun 2026, with sales of ₹33.04 crore and net profit of ₹1.85 crore. GKB Ophthalmics Ltd’s annual general meeting is scheduled for 25 Aug 2026. Figures are as of 25 Aug 2026 and are not real time.
GKB Ophthalmics Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
GKB Ophthalmics Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹33.04 cr, up 2.3% from ₹32.31 cr a year earlier. Net profit turned positive at ₹1.85 cr.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 26.14 | 25.8 | 31.02 | 32.31 | 30.17 | 56.79 | 29.79 | 33.04 |
| Expenses | 26.2 | 26.74 | 33.88 | 31.51 | 27.15 | 55.13 | 26.71 | 30.41 |
| Operating profit | -0.06 | -0.94 | -2.86 | 0.8 | 3.02 | 1.66 | 3.08 | 2.63 |
| OPM % | -0.23% | -3.64% | -9.22% | 2.48% | 10.01% | 2.92% | 10.34% | 7.96% |
| Other income | 0.28 | 0.48 | 0.35 | 0.21 | 0.37 | 0.57 | -0.68 | 0.73 |
| Interest | 0.55 | 0.63 | 0.63 | 0.77 | 0.66 | 0.73 | 0.52 | 0.51 |
| Depreciation | 0.77 | 0.77 | 0.8 | 0.8 | 0.82 | 0.82 | 0.8 | 0.8 |
| Profit before tax | -1.1 | -1.86 | -3.94 | -0.56 | 1.91 | 0.68 | 1.08 | 2.05 |
| Tax % | 5.45% | 2.69% | 4.82% | 14.29% | 3.66% | -4.41% | -3.70% | 9.76% |
| Net profit | -1.15 | -1.91 | -4.13 | -0.64 | 1.84 | 0.7 | 1.12 | 1.85 |
| EPS (₹) | -2.42 | -4.03 | -7.04 | -2.02 | 3.17 | 0.87 | 0.38 | 2.00 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
GKB Ophthalmics Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 57 | 71 | 75 | 88 | 109 | 149 | 150 |
| Operating profit | 2 | 5 | 4 | 1 | -3 | 9 | 10 |
| OPM % | 4.0% | 7% | 4.9% | 0.6% | -2.5% | 6% | 7% |
| Net profit | -1 | 2 | 0 | -3 | -7 | 3 | 6 |
| EPS (₹) | -1.81 | 2.52 | -0.34 | -5.57 | -13.97 | 2.22 | 6.42 |
TTM is the trailing twelve months to the most recent quarter.
GKB Ophthalmics Ltd growth and returns
- 10 Years
- 13%
- 5 Years
- 21%
- 3 Years
- 25%
- TTM
- 30%
- 10 Years
- 11%
- 5 Years
- 77%
- 3 Years
- 138%
- TTM
- 147%
- 10 Years
- -6%
- 5 Years
- -8%
- 3 Years
- -11%
- 1 Year
- -22%
- 10 Years
- -2%
- 5 Years
- -2%
- 3 Years
- -5%
- Last Year
- 3%
GKB Ophthalmics Ltd shareholding pattern
Promoters held 51.15% at Jun 2026, broadly unchanged since Jun 2025. FIIs 1.79%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 50.95% | 50.98% | 50.99% | 51.06% | 51.06% | 51.13% | 51.13% | 51.15% |
| FIIs | 1.79% | 1.79% | 1.79% | 1.79% | 1.79% | 1.79% | 1.79% | 1.79% |
| Public | 47.28% | 47.23% | 47.23% | 47.16% | 47.17% | 47.09% | 47.09% | 47.07% |
| No. of shareholders | 2,510 | 2,539 | 2,538 | 2,550 | 2,601 | 2,661 | 2,634 | 2,557 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
When is GKB Ophthalmics Ltd’s AGM?
GKB Ophthalmics Ltd’s annual general meeting is scheduled for 25 Aug 2026.
- AGMProceedings and outcome of the 44th Annual General Meeting
See the full results calendar for every Indian company reporting in the next 30 days.
GKB Ophthalmics Ltd corporate filings
- The 44th Annual General Meeting of the Company was held today i.e Tuesday , August 25th, 2026, at 11.00 A. M., at the Registered Office of the Company at 16- A, Tivim Industrial Estate, ....AGM/EGMlow impact
Cruxal's analysis: GKB Ophthalmics Ltd. held its 44th Annual General Meeting on August 25, 2026, to address…
Read the full analysis - Announcement under Regulation 30 (LODR)-Newspaper PublicationCompany Updatemedium impact
Cruxal's analysis: GKB Ophthalmics Ltd. has released its unaudited standalone and consolidated financial…
Read the full analysis - Enclosed please find the unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. The above unaudited Financial Results and the Limited Review Reports ....Resulthigh impact
Cruxal's analysis: GKB Ophthalmics Limited reported consolidated revenue from operations of 33.04 crore for…
Read the full analysis - The meeting of the Board of Directors of the Company was held on August 12, 2026 which considered and took on record inter alia the unaudited Standalone and Consolidated Financial Results ....Board Meetinghigh impact
Cruxal's analysis: GKB Ophthalmics Limited reported Q1 FY27 standalone revenue of 6.40 crore and a net loss…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track GKB Ophthalmics Ltd
Cruxal reads every GKB Ophthalmics Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.